Westhouse Medical Services Plc
FRA:5WM ISIN:GB00B6YWDK49
Test for Breast Cancer and a patented procedure to treat glaucoma. www.westhousemedical.com
News
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces that its Chairman, Jack Kaye has joined in an advisory capacity, the Committee on Advanced Technology for the US based International Charity, "The Cure is Now". The Cure is Now (www.TheCureisNow.org) is committed to funding and supporting the highest quality research that has the greatest potential to make a significant impact on the scientific community and patients throughout the world.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) announced today that Mr Walter S Issler of Switzerland has been appointed as the new CEO of Westhouse to take the firm through to realize its initial expansion and product development program globally.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) announced today that Mr Jack Kaye has stepped down as CEO of Westhouse to allow himself the time to pursue other business activities. Mr Kaye will remain as an advisor to the company and feels that it is time to pass the reins on to others to carry the company forward. Mr Kaye stated that "a new executive and management team will allow Westhouse to continue its acquisition expansion throughout Europe and in the USA and to bring the current assets into profitability."
Sunridge International (PINK:SNDZ) announced today that it has received a $1,000,000 payment from Westhouse Medical of the United Kingdom, as partial payment towards the purchase of assets from Sunridge International. Another $1,000,000 payment will be made when the sale is concluded in approximately 45 days.
Westhouse Medical Services plc (FRA:5WM) confirms that at its Annual General Meeting held today, Wednesday 23rd May 2012 all proposed resolutions were unanimously approved by Shareholders
Healthcare Specialist, Westhouse Medical Services Plc. (FRA:5WM) announced today that it has secured US$50M in additional funding through Wedgewood Investment Group of New York in the form of two $25 million gold secured bonds. This allows Westhouse to continue it's acquisition expansion throughout Europe and in the USA.
Healthcare Specialist, Westhouse Medical Services Plc. (FRA:5WM) today announces it has commenced the process for dual listing on the OTCQX, alongside its present listing on the Frankfurt Stock Exchange (FSE). Soloway Group, a licensed Principal American Liaison, will handle and advise on the OTCQX listing procedure.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces it has published its audited financial results for 2011 year-end accounts. Copies of the financial statement and its analysis are available for viewing and downloading in the 'Investor' section of the company's website.
Westhouse Medical Services (FRA:5WM) Secures US$50M in Additional Funding and Expands Executive Team
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) announced today that it has secured US$50M in additional funding through Wedgewood Investment Group of New York in the form of two $25 million gold secured bonds. This allows Westhouse to continue it's acquisition expansion throughout Europe and in the USA.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) announces it will be holding its Annual General Meeting for Shareholders on Wednesday, 23rd May 2012, 10am at The Westbury Hotel, Conduit Street, London W1.
39,929 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 17) (Last 30 Days: 171) (Since Published: 20221)